Perbedaan DCI Indonesia Tbk dan Charlie Hospital Semarang Tbk.: DCI Indonesia Tbk diperdagangkan di Rp198.675 (kapitalisasi pasar 473,71 T, volume 24 jam 1 rb), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp256 (kapitalisasi pasar 715,5 M, volume 24 jam 30,64 jt). Perbedaan utamanya: DCI Indonesia Tbk jauh lebih besar — sekitar 662,1× kapitalisasi pasar Charlie Hospital Semarang Tbk., dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (30,64 jt vs 1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DCII | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 473,71 T | 715,5 M |
Volume | 1 rb | 30,64 jt |
Lot | 10 | 306,41 rb |
Perputaran | 194,12 jt | 7,98 M |
Harga Rata-rata | 194.120 | 260,34 |
Nilai Transaksi | 194,12 jt | 7,98 M |
Harga Ekuilibrium Indikatif | 199.000 | 256 |
Volume Ekuilibrium Indikatif | 1 | 512 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Selengkapnya di halaman DCII →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →